Novo Nordisk
NVO
#103
Rank
NZ$286.77 B
Marketcap
NZ$64.61
Share price
0.65%
Change (1 day)
-43.78%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) Fails to deliver data

Key failure to deliver metrics for Novo Nordisk:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novo Nordisk (NVO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013

Volume in USD (price x number of shares), data since 2013

Novo Nordisk (NVO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$0.21 B-40.9%
2025NZ$0.36 B47.59%
2024NZ$0.24 B179.42%
2023NZ$88.71 M-11.66%
2022NZ$0.10 B125.23%
2021NZ$44.58 M70.14%
2020NZ$26.2 M-57.24%
2019NZ$61.28 M-22.47%
2018NZ$79.04 M3.14%
2017NZ$76.63 M5.66%
2016NZ$72.53 M-28.24%
2015NZ$0.10 B-51.63%
2014NZ$0.20 B598.64%
2013NZ$29.9 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
NZ$45.54 MNZ$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$27.23 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$1.29 MNZ$70.46 M๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$42.45 MNZ$72.09 M๐Ÿ‡บ๐Ÿ‡ธ USA